The Ottawa Hospital, a leading academic health, research, and learning hospital, offers comprehensive care for multiple myeloma, including expert hematology services, research, and clinical trials, and is affiliated with the University of Ottawa. 

• Comprehensive Cancer Care:The Ottawa Hospital Cancer Program aims to provide world-class cancer care, encompassing prevention, assessment, treatment, support, follow-up, and end-of-life care. 
• Hematology Program:The Ottawa Hospital Hematology Program provides expert care and management for diseases of the lymph glands, blood, or bone marrow, including multiple myeloma. 
• Expert Team:The program features a multidisciplinary team of hematologists, including Dr. Christopher Bredeson (Head of Malignant Hematology and Stem Cell Transplantation) and Dr. Marc Carrier (Chief, Division of Hematology). 
• Research and Clinical Trials:The Ottawa Hospital is actively involved in research to improve the understanding and treatment of blood cancers like multiple myeloma, including conducting clinical trials and offering experimental therapies. 
• Transplantation and Cellular Therapy:The Ottawa Hospital has a Transplantation and Cellular Therapy Program that treats various blood disorders, including multiple myeloma, and offers stem cell transplant and CAR T-cell therapy. 
• Patient Education and Resources:The Ottawa Hospital provides patient education, information, and resources to help patients and their families understand their diagnosis, treatment, and manage symptoms and emotions. 
• Supportive and Palliative Care:The hospital offers supportive and palliative care services, including an award-winning CARE program for those with malignant effusions. 
• Location:The Ottawa Hospital Hematology Program is located at 501 Smyth Road, K1H 8L6. 
• Referral Process:Referrals to the Hematology Program are accepted only from physicians and can be faxed to the Hematology office.